BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21870995)

  • 1. Therapeutic targeting of B7-H1 in breast cancer.
    Hasan A; Ghebeh H; Lehe C; Ahmad R; Dermime S
    Expert Opin Ther Targets; 2011 Oct; 15(10):1211-25. PubMed ID: 21870995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.
    Zhang C; Wang W; Qin X; Xu Y; Huang T; Hao Q; Li W; Wu S; Zhang Y
    Oncol Rep; 2013 Nov; 30(5):2442-8. PubMed ID: 23970300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.
    Ghebeh H; Lehe C; Barhoush E; Al-Romaih K; Tulbah A; Al-Alwan M; Hendrayani SF; Manogaran P; Alaiya A; Al-Tweigeri T; Aboussekhra A; Dermime S
    Breast Cancer Res; 2010; 12(4):R48. PubMed ID: 20626886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
    Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
    Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells.
    Ghebeh H; Tulbah A; Mohammed S; Elkum N; Bin Amer SM; Al-Tweigeri T; Dermime S
    Int J Cancer; 2007 Aug; 121(4):751-8. PubMed ID: 17415709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis.
    Groeger S; Domann E; Gonzales JR; Chakraborty T; Meyle J
    Immunobiology; 2011 Dec; 216(12):1302-10. PubMed ID: 21723642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.
    Ye Y; Zhou L; Xie X; Jiang G; Xie H; Zheng S
    J Surg Oncol; 2009 Nov; 100(6):500-4. PubMed ID: 19697355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of B7-H1 overexpression in kidney cancer.
    Thompson RH; Kwon ED
    Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of B7-H1 expressed by human uveal melanoma cells.
    Jia R; Jiao Z; Xu X; Wang J; Zhou Y; Song X; Ge S; Fan X
    Mol Med Rep; 2011; 4(1):163-7. PubMed ID: 21461580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone.
    Afreen S; Dermime S
    Hematol Oncol Stem Cell Ther; 2014 Mar; 7(1):1-17. PubMed ID: 24398144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.
    Wiendl H; Mitsdoerffer M; Schneider D; Chen L; Lochmüller H; Melms A; Weller M
    FASEB J; 2003 Oct; 17(13):1892-4. PubMed ID: 12923066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.
    Jiang W
    Vaccine; 2012 Jan; 30(4):758-66. PubMed ID: 22133510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.
    Tamura H; Ishibashi M; Yamashita T; Tanosaki S; Okuyama N; Kondo A; Hyodo H; Shinya E; Takahashi H; Dong H; Tamada K; Chen L; Dan K; Ogata K
    Leukemia; 2013 Feb; 27(2):464-72. PubMed ID: 22828443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).
    Lee SJ; Jang BC; Lee SW; Yang YI; Suh SI; Park YM; Oh S; Shin JG; Yao S; Chen L; Choi IH
    FEBS Lett; 2006 Feb; 580(3):755-62. PubMed ID: 16413538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.
    Boland JM; Kwon ED; Harrington SM; Wampfler JA; Tang H; Yang P; Aubry MC
    Clin Lung Cancer; 2013 Mar; 14(2):157-63. PubMed ID: 22868219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis.
    Cao Y; Zhang L; Ritprajak P; Tsushima F; Youngnak-Piboonratanakit P; Kamimura Y; Hashiguchi M; Azuma M
    Cancer Res; 2011 Jul; 71(14):4737-41. PubMed ID: 21730022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
    Thompson RH; Dong H; Kwon ED
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
    Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
    Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.
    Dong H; Strome SE; Matteson EL; Moder KG; Flies DB; Zhu G; Tamura H; Driscoll CL; Chen L
    J Clin Invest; 2003 Feb; 111(3):363-70. PubMed ID: 12569162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
    Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.